Research
Energy balance
Tirzepatide induces significant weight loss: 7.5 kg (5 mg/week), 11 kg (10 mg/week), and 12 kg (15 mg/week) compared to placebo.
TZP can be considered for weight management in patients with T2D and obesity.
StrongSupportsmedium confidence
Compared to placebo, TZP induces a significant weight loss: 7.5 (5 mg/week); 11 (10 mg/week); and 12 kg (15 mg/week).
Why this rating
Based on data from human studies.
Source
Is Tirzepatide the New Game Changer in Type 2 Diabetes?
Giuseppe Lisco et al. · Endocrines · 2024
reviewCited 7×
Read the paper This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →